Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

TOX-56: Carisoprodol (78-44-4)


Study Results


Genetic Toxicology

An overview of Genetic Toxicology Micronucleus Mice study conclusions related to TOX-56: Carisoprodol (78-44-4).
Micronucleus - Mice
View
  • Male: Negative
    Female: Negative
An overview of Genetic Toxicology Mammalian Cell Mutagenicity study conclusions related to TOX-56: Carisoprodol (78-44-4).
Mammalian Cell Mutagenicity
View
  • Positive
An overview of Genetic Toxicology Mammalian Cell Cytogenetics study conclusions related to TOX-56: Carisoprodol (78-44-4).
Mammalian Cell Cytogenetics
CA SCE
An overview of Genetic Toxicology Bacterial Mutagenicity study conclusions related to TOX-56: Carisoprodol (78-44-4).
Bacterial Mutagenicity
View
  • Negative

Citation Information


NTP. TOX-56: Carisoprodol (78-44-4). Chemical Effects in Biological Systems (CEBS). Research Triangle Park, NC (USA): National Toxicology Program (NTP).

Publications


TOX-56 Toxicity Studies of Carisoprodol (CASRN 78-44-4) Administered by Gavage to F344/N Rats and B6C3F1 Mice

Study Data


Toxicity and Carcinogenicity Studies


3-Month Evaluation of the Toxicity (C56235B) of Carisoprodol (78-44-4) in F344/N Rats Exposed via Gavage
3-Month Evaluation of the Toxicity (C56235C) of Carisoprodol (78-44-4) in F344/N Rats Exposed via Gavage
3-Month Evaluation of the Toxicity (C56235B) of Carisoprodol (78-44-4) in B6C3F1 Mice Exposed via Gavage
3-Month Evaluation of the Toxicity (C56235C) of Carisoprodol (78-44-4) in B6C3F1 Mice Exposed via Gavage

Genetic Toxicology Studies


Genetic Toxicity Evaluation of Carisoprodol (78-44-4) in Micronucleus Study A09820 in B6C3F1 Mice
Genetic Toxicity Evaluation of Carisoprodol in Salmonella/E.coli Mutagenicity Test or Ames Test. Study 238333
Summary Data